A retrospective real-world study for nimotuzumab plus postoperative adjuvant chemotherapy for resectable pancreatic cancer

被引：0
|
作者：
Zou, S. [1 ]
Zhan, Q. [1 ]
Wen, C. [1 ]
Li, F. [1 ]
Zhao, S. [1 ]
Jiang, L. [1 ]
Chen, H. [1 ]
Deng, X. [1 ]
Shen, B. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Gen Surg, Ruijin Hosp, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1681P
引用
收藏
页码：S921 / S921
页数：1
相关论文
共 50 条
  • [41] Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial
    Neoptolemos, JP
    Dunn, JA
    Stocken, DD
    Almond, J
    Link, K
    Beger, H
    Bassi, C
    Falconi, M
    Pederzoli, P
    Dervenis, C
    Fernandez-Cruz, L
    Lacaine, F
    Pap, A
    Spooner, D
    Kerr, DJ
    Friess, H
    Büchler, MW
    [J]. LANCET, 2001, 358 (9293): : 1576 - 1585
  • [42] Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: Continue or stop?
    Ren, Fang
    Xu, Ying-Chun
    Wang, Hong-Xia
    Tang, Lei
    Ma, Yue
    [J]. PANCREATOLOGY, 2012, 12 (02) : 162 - 169
  • [43] NEONAX: NEOADJUVANT PLUS ADJUVANT OR ONLY ADJUVANT NAB-PACLITAXEL PLUS GEMCITABINE FOR RESECTABLE PANCREATIC CANCER: A PHASE II STUDY OF THE AIO PANCREATIC CANCER GROUP
    Thomas, Ettrich
    Andreas, Berger
    Rainer, Muche
    Manfred, Lutz
    Nicole, Prasnikar
    Waldemar, Uhl
    Andrea, Tannapfel
    Volker, Heinemann
    Thomas, Seufferlein
    [J]. ANNALS OF ONCOLOGY, 2014, 25 : 85 - 85
  • [44] Real-world evidence for dose reduced preoperative chemotherapy in the older population with resectable gastroesophageal cancer
    Skjoldbirk, J.
    Egebjerg, K.
    Qvortrup, C.
    Lund, C.
    Baeksgaard, L.
    Achiam, M.
    Mau-Soerensen, P.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S112 - S112
  • [45] Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer
    Herman, Joseph M.
    Fan, Katherine Y.
    Wild, Aaron T.
    Hacker-Prietz, Amy
    Wood, Laura D.
    Blackford, Amanda L.
    Ellsworth, Susannah
    Zheng, Lei
    Le, Dung T.
    De Jesus-Acosta, Ana
    Hidalgo, Manuel
    Donehower, Ross C.
    Schulick, Richard D.
    Edil, Barish H.
    Choti, Michael A.
    Hruban, Ralph H.
    Pawlik, Timothy M.
    Cameron, John L.
    Laheru, Daniel A.
    Wolfgang, Christopher L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (04): : 678 - 685
  • [46] Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer
    Lund, Jennifer Leigh
    Webster-Clark, Michael
    Bratton, Emily W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [47] The effect of time to adjuvant chemotherapy on survival in nonmetastatic resectable pancreatic adenocarcinoma: A retrospective analysis
    Pisa, A.
    Pericay, C.
    Dotor, E.
    Alfaro, J.
    Orellana, R.
    Pujal, M.
    Amador, M. A.
    Garcia Borobia, F.
    Mato, R.
    Saigi, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
    Pengfei Su
    Lin Jiang
    Yingjing Zhang
    Tian Yu
    Hongyun Huang
    Moxi Chen
    Can Cao
    Weiming Kang
    Yuqin Liu
    Jianchun Yu
    [J]. European Journal of Medical Research, 28
  • [49] Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
    Su, Pengfei
    Jiang, Lin
    Zhang, Yingjing
    Yu, Tian
    Huang, Hongyun
    Chen, Moxi
    Cao, Can
    Kang, Weiming
    Liu, Yuqin
    Yu, Jianchun
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [50] A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
    Fujimoto, Daichi
    Miura, Satoru
    Yoshimura, Kenichi
    Wakuda, Kazushige
    Oya, Yuko
    Haratani, Koji
    Itoh, Shoichi
    Uemura, Takehiro
    Morinaga, Ryotaro
    Takahama, Takayuki
    Nakashima, Kazuhisa
    Tachihara, Motoko
    Saito, Go
    Tanizaki, Junko
    Otsubo, Kohei
    Ikeda, Satoshi
    Matsumoto, Hirotaka
    Hara, Satoshi
    Hata, Akito
    Masuda, Takeshi
    Yamamoto, Nobuyuki
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (02):
12345